Locations
San Mateo, CA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Series B
founded in
2019
Big Hat Biosciences is a Series B biotech company based outside San Francisco that leverages machine learning and synthetic biology to design safer and more effective antibody therapies. Their Milliner platform integrates a high-speed wet lab with advanced machine learning technologies, enabling the rapid synthesis, purification, and characterization of hundreds of recombinant antibodies weekly. With a pipeline of wholly-owned and partnered therapeutic programs, Big Hat has raised over $100 million from top investors and is recognized for its innovative approach to tackling complex diseases through next-generation antibody therapies.
Something looks off?On-site & Remote